Global Positive Patient Identification (PPID) Market Growth (Status and Outlook) 2025-2031

According to this study, the global Positive Patient Identification (PPID) market size will reach US$ million by 2031.

Positive patient identification refers to a combination of hardware and software solutions designed for identifying a patient’s details so as to ensure correct medication is provided to the same.

United States market for Positive Patient Identification (PPID) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Positive Patient Identification (PPID) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Positive Patient Identification (PPID) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Positive Patient Identification (PPID) players cover Imprivata, Inc., RightPatient, Inc., General Data Company, Inc., GBS Corporation, MSoft eSolutions Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Positive Patient Identification (PPID) Industry Forecast” looks at past sales and reviews total world Positive Patient Identification (PPID) sales in 2024, providing a comprehensive analysis by region and market sector of projected Positive Patient Identification (PPID) sales for 2025 through 2031. With Positive Patient Identification (PPID) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Positive Patient Identification (PPID) industry.

This Insight Report provides a comprehensive analysis of the global Positive Patient Identification (PPID) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Positive Patient Identification (PPID) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Positive Patient Identification (PPID) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Positive Patient Identification (PPID) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Positive Patient Identification (PPID).

This report presents a comprehensive overview, market shares, and growth opportunities of Positive Patient Identification (PPID) market by product type, application, key players and key regions and countries.

Segmentation by Type:
Scanning Devices
Software
Services

Segmentation by Application:
Web Based
Cloud Based

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Imprivata, Inc.
RightPatient, Inc.
General Data Company, Inc.
GBS Corporation
MSoft eSolutions Ltd.
PatientWorks Corporation
SATO Holdings Corporation
Zebra Technologies
RMS Omega Technologies Group, Inc.

Please note: The report will take approximately 2 business days to prepare and deliver. Show more